Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients
- 30 September 1997
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 33 (10), 1627-1633
- https://doi.org/10.1016/s0959-8049(97)00282-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Promiscuous translocations of chromosome arm 17q in human neuroblastomasGenes, Chromosomes and Cancer, 1997
- Comparative genomic hybridization study of primary neuroblastoma tumorsGenes, Chromosomes and Cancer, 1997
- Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomasGenes, Chromosomes and Cancer, 1996
- Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in NeuroblastomaEuropean Journal of Cancer, 1995
- Comparative genomic hybridization in acute myeloid leukemia: A comparison with G-banding and chromosome paintingCancer Genetics and Cytogenetics, 1995
- Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastomaMedical and Pediatric Oncology, 1995
- Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumorsGenes, Chromosomes and Cancer, 1994
- I;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell linesGenes, Chromosomes and Cancer, 1994
- Cytogenetic abnormalities of small round cell tumoursMedical and Pediatric Oncology, 1994
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993